Venus Remedies Secures GMP Certification from Moldova for Antibiotic-Carbapenem Manufacturing Facility
Venus Remedies proudly announces its latest achievement: receiving Good Manufacturing Practices (GMP) certification from the Ministry of Health of Moldova for its antibiotic-carbapenem manufacturing facility.
This certification was granted after a comprehensive inspection conducted in October 2024, with final approval granted in December 2024. This achievement reaffirms the company’s commitment to producing high-quality, reliable pharmaceuticals to meet global standards.
Carbapenems, a class of broad-spectrum antibiotics, are essential in treating severe bacterial infections. With this GMP certification, Venus Remedies has strengthened its position as a global leader in the antibiotic market.
In 2024, Venus Remedies established itself as one of the top five pharmaceutical exporters from India to Moldova. The GMP certification is expected to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026. With this certification, the company is well-positioned to extend its presence in the Eastern European market.
Moldova's pharmaceutical market is experiencing promising growth, expecting a Compound Annual Growth Rate of 3.22% between 2024 and 2029. By the end of this period, the market is projected to reach a volume of $83.32 million. This expansion is primarily fueled by the growing availability of affordable generic medicines and the increasing popularity of online pharmacies, which have significantly enhanced healthcare accessibility for consumers across the country.
Indian pharmaceutical exports, particularly in antibiotics, oncology treatments, and hormones, are among the leading therapy areas in Moldova. With the GMP certification in place, Venus Remedies will be able to offer Moldovan healthcare providers and patients access to top-quality antibiotics, ensuring they have effective and safe treatment options. This achievement further solidifies Venus’ commitment to expanding its reach and providing reliable healthcare solutions in Moldova and throughout Eastern Europe.
